Shammas Bajwa to Humans
This is a "connection" page, showing publications Shammas Bajwa has written about Humans.
Connection Strength
0.024
-
Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review. Cancer Invest. 2023 Sep; 41(8):739-749.
Score: 0.013
-
Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta-analysis. J Neuroendocrinol. 2022 07; 34(7):e13149.
Score: 0.012